KYNB
KYNB
NASDAQ · Biotechnology

Kyntra Bio Inc

$7.55
+0.24 (+3.28%)
As of Jun 30, 10:44 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 6 75%
Hold 2 25%
Sell 0 0%
Price Target
Analyst Price Target +322.6% upside
Low Target $24.67
Average Target $31.91
High Target $44.05
Current Price $7.55
Current
$7.55
Target
$31.91
$24.67 $31.91 avg $44.05
Scenario Analysis
Bear Case
$24.67
226.8%
Low target
Base Case
$31.91
+322.6%
Avg target
Bull Case
$44.05
+483.4%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$12.60
-40.1% from high
52-Week Low
$4.85
+55.7% from low
Target vs 52W High
$31.91
+153.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%